| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Lb Pharmaceuticals IncLBRX | +16.87% | $34.26 | $40.04 | 2026-10-06 - 2026-11-19 | Strong Buy |
Neurocrine Biosciences IncNBIX | +7.61% | $145.51 | $156.59 | 2026-10-06 - 2026-11-19 | Strong Buy |
Xenon Pharmaceuticals IncXENE | +2.71% | $36.57 | $37.56 | 2026-10-06 - 2026-11-19 | Strong Buy |
Ovid Therapeutics IncOVID | 0.00% | $2.34 | $2.34 | 2026-10-05 - 2026-11-19 | Strong Buy |
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rapport Therapeutics IncRAPP | 3 | Strong Buy | $66.00 | +179.78% | Maintains | 15 days ago |
Neurocrine Biosciences IncNBIX | 2 | Strong Buy | $224.00 | +43.05% | Maintains | 16 days ago |
Lb Pharmaceuticals IncLBRX | 1 | Strong Buy | $80.00 | +99.80% | Initiates Coverage On | a month ago |
Xenon Pharmaceuticals IncXENE | 1 | Strong Buy | $73.00 | +94.36% | Assumes | a month ago |
Ovid Therapeutics IncOVID | 2 | Strong Buy | $7.00 | +199.15% | Initiates Coverage On | a month ago |
Maplight Therapeutics IncMPLT | 1 | Hold | N/A | N/A | Initiates Coverage On | a month ago |